Small Cell Lung Cancer: A New Era Is Beginning?

Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer: No significant progress has been made in finding new treatments for decades and platinum-based chemotherapy has for a long time represented the standard of care. This therapeutic scenario has recently changed, thanks to positi...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
מחברים אחרים:	Morabito, Alessandro (Editor), Rolfo, Christian (Editor)
פורמט:	Book Chapter
יצא לאור:	Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
נושאים:	Medicine immune checkpoint inhibitors extensive-stage small cell lung cancer nivolumab ipilimumab pembrolizumab atezolizumab durvalumab chemotherapy small-cell lung cancer lobectomy pneumonectomy radiotherapy multimodal treatment immunotherapy SCLC PARP DDR ICB synthetic lethality SLFN11 STING pathology and classification of SCLC biology of SCLC immune-checkpoint inhibitors in SCLC small cell lung cancer Immunotherapy extensive disease lurbinectedin gene pathway pathobiology targeted therapy circulating tumor cells prognostic biomarker targeted agents n/a
גישה מקוונת:	Get Fullteks DOAB: description of the publication
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

אינטרנט

Get Fullteks
DOAB: description of the publication

3rd Floor Main Library

פרטי מלאי ספרים מ 3rd Floor Main Library
סימן המיקום:	A1234.567
עותק 1	זמין

Small Cell Lung Cancer: A New Era Is Beginning?

אינטרנט

3rd Floor Main Library

פריטים דומים